Fig. 4From: Intranasal administration enhances size-dependent pulmonary phagocytic uptake of poly(lactic-co-glycolic acid) nanoparticlesPreferential uptake of PLGA-NH2 nanoparticles (900 nm) by lung immune cells. a Gating strategy for the identification of lung immune cells. b Analysis of nanoparticle uptake by lung-resident immune cells at 1, 6, 12, and 48 h after intranasal administration. Data are presented as mean ± SEM (n = 3). PLGA: poly(lactic-co-glycolic acid)Back to article page